A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

Clinical trial NCT03443843 · COMPLETED

Trial details

NCT number: NCT03443843
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rhinitis, Allergic

Start date: 2018-02-21
Primary completion: 2018-05-11
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.